Bafna Pharmaceuticals Limited — Others, 26-06-2025: Trading Window

Bafna Pharmaceuticals has announced a board meeting on the financial results for the quarter and half-year ending June 30, 2025. The company has also declared a trading window closure for designated persons and their immediate relatives from July 1, 2025, until 48 hours after the financial results are published, to prevent insider trading. This trading restriction ensures compliance and maintains market integrity around the earnings announcement, safeguarding shareholder interests.